4Filing Date: Aug 17, 2026

Axon Enterpri

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001628280-26-057438
Total Value$0
Trades1
Insiders1

Transaction Details

Brooks Cameron
CHIEF REVENUE OFFICER·Direct
Grant · Acquire
Common Stock
Shares+15.81K
Price$0.00
Total Value$0
Shares Owned After67.98K
Transaction DateAug 16, 2026
Footnotes ▸

The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on April 1, 2024 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on April 1, 2027, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Post-Transaction Holdings

Brooks Cameron · CHIEF REVENUE OFFICER
SecuritySharesChange
Common Stock67.98K+15.81K (30.30%)
auto_awesome

Deep Analysis

Axon Chief Revenue Officer Cameron Brooks received 15,810 performance-based restricted stock units (XSUs) as a grant — no shares bought or sold.

lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-16 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: AXON ENTERPRISE, INC. (AXON) CIK: 0001069183 --- Reporting Owner --- Name: Brooks Cameron CIK: 0002017144 Role: Officer (CHIEF REVENUE OFFICER) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-16 | Code: A (Grant or award) Shares: +15,810 | Price: $0.00 Shares Owned After: 67,980.933 | Ownership: D (Direct) Footnotes: [F1] The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on April 1, 2024 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on April 1, 2027, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes. --- Footnotes (Complete Index) --- F1: The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on April 1, 2024 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on April 1, 2027, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes. --- Signature --- /s/ /s/ Cameron Brooks by Isaiah Fields, Attorney-in-Fact (2026-08-17)

keid analysis is for reference only and does not constitute investment advice.